Clinical Trial Update: Comparative Effectiveness of Tirzepatide Versus Sitagliptin in Individuals at Cardiovascular Risk (TIRZSITA-CVOT)

View source ↗

Summary

A completed trial comparing tirzepatide to sitagliptin in adults with type 2 diabetes and cardiovascular risk evaluates comparative effectiveness on cardiovascu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerotic Cardiovascular Disease
• Type 2 Diabetes Mellitus

Drugs mentioned

• Januvia (sitagliptin)
• MOUNJARO (tirzepatide)

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Type2 Diabetes Mellitus, Atherosclerotic Cardiovascular Disease | Status: COMPLETED